| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |